These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33607533)
21. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
22. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537 [TBL] [Abstract][Full Text] [Related]
23. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT. Weiler-Sagie M; Kagna O; Dann EJ; Ben-Barak A; Israel O Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1133-40. PubMed ID: 24570095 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis. Kim SJ; Lee JS World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis. Kim DH; Kim SJ Clin Imaging; 2020 Sep; 65():100-107. PubMed ID: 32387798 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
28. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients. Chen S; Wang S; He K; Ma C; Fu H; Wang H Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis. Kim SJ; Pak K; Kim K Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881 [TBL] [Abstract][Full Text] [Related]
30. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Ujjani CS; Hill EM; Wang H; Nassif S; Esposito G; Ozdemirli M; Cordova C; Cheson BD Br J Haematol; 2016 Aug; 174(3):410-6. PubMed ID: 27098364 [TBL] [Abstract][Full Text] [Related]
31. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma. Badr S; Kotb M; Elahmadawy MA; Moustafa H Clin Nucl Med; 2018 Dec; 43(12):e428-e438. PubMed ID: 30358625 [TBL] [Abstract][Full Text] [Related]
32. Whole-body MRI versus an [ Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; de Keizer B; Nievelstein RAJ Eur Radiol; 2021 Dec; 31(12):8925-8936. PubMed ID: 34021390 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549 [TBL] [Abstract][Full Text] [Related]
34. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Moulin-Romsee G; Hindié E; Cuenca X; Brice P; Decaudin D; Bénamor M; Brière J; Anitei M; Filmont JE; Sibon D; de Kerviler E; Moretti JL Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1095-105. PubMed ID: 20204358 [TBL] [Abstract][Full Text] [Related]
35. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis. Seol HY; Kim YS; Kim SJ Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Characterization of Intraductal Papillary Mucinous Neoplasms: An Updated Systematic Review and Meta-analysis. Kim K; Kim SJ Pancreas; 2021 Mar; 50(3):353-361. PubMed ID: 33835966 [TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. Pakos EE; Fotopoulos AD; Ioannidis JP J Nucl Med; 2005 Jun; 46(6):958-63. PubMed ID: 15937306 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of Ko WS; Kim SJ Hell J Nucl Med; 2023; 26(2):132-139. PubMed ID: 37527049 [TBL] [Abstract][Full Text] [Related]
39. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937 [TBL] [Abstract][Full Text] [Related]
40. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]